Validation and Assessment of Novel Morphology-Voltage-P-wave Score for Diagnosing Left Ventricular Diastolic Dysfunction in Patients With Hypertension
Recruiting · NCT06779513 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Echocardiohraphy
What this trial is about
This study aimed to assess and validate the diagnostic utility of a novel Morphology-Voltage-P-wave Score (MVP Score) in identifying left ventricular diastolic dysfunction among patients with hypertension. Researchers will collect information of patient with hypertension and underwent transthoracal echocardiography assessment. The data consist of demographic data, clinical presentation, laboratory, and echocardiography result were collected by two investigators. Then, the data was analyzed by using IBM SPSS Statistics v26.
Who can take part
Age range
18 Years to 70 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Essential hypertension
Exclusion criteria
- Secondary or resistant hypertension
- LVEF\<55%
- Congenital heart disease
- Infiltrative cardiomyopathy
- Coronary artery disease
- Chronic kidney disease
- Valvular heart disease
- Bundle branch block
- Arrhythmia
Where it is running
1 location listed.
- Dr. Kariadi Central General Hospital - Semarang, Central of Java, Indonesia